MRI AI model study for midline brain tumors
Part of Cancer clinical trials.
This study uses artificial intelligence to analyze MRI scans of midline brain tumors (gliomas) to help predict how the disease may progress and improve treatment planning. Researchers are collecting data from multiple hospitals to teach an AI system to better understand these tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a diffuse glioma (a type of brain tumor) confirmed by a biopsy or tissue sample
- Your tumor is located in the midline of your brain (the center area)
- You had an MRI scan before surgery or treatment
- Your medical records and test results are complete and available
- Your MRI images are clear and of good quality (not too blurry or damaged)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an AI tool that helps diagnose brain tumors like glioma, brain metastases, and lymphoma using MRI scans. It may allow faster and more accurate diagnosis without needing additional tests.
This trial uses artificial intelligence to analyze MRI scans from people diagnosed with a type of brain tumor called glioma. It aims to better understand the cancer from diagnosis through treatment, which could help guide future care.
This study is testing if artificial intelligence (AI) can look at microscope slides of your brain tumor tissue to guess its genetic makeup. It uses data already collected from your routine care, so there is no extra treatment or medicine involved.
This study uses brain MRI images and tumor tissue to predict the tumor’s molecular (cell-level) features in people with glioma. It may help doctors better understand glioma biology and plan care based on noninvasive imaging plus lab testing.
This trial uses an AI computer program to predict the molecular features of a primary brain tumor (glioma) by looking at tumor tissue images. Your results could help researchers better match glioma subtypes to more tailored care, using information obtained from the surgery sample.
This trial tests whether artificial intelligence can help plan radiation therapy better for people with a type of brain cancer called glioblastoma. It may lead to more precise treatment and fewer side effects.
Hear when a new Glioma Glioblastoma Multiforme trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.